4 news items
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
CHRS
9 May 24
For Media:Jodi SieversVP, Corporate Communications
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
CHRS
8 Apr 24
@coherus.com For Media:Jodi SieversVP, Corporate Communications
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
CHRS
13 Mar 24
:Jodi SieversVP, Corporate Communications
Coherus Completes Divestiture of Ophthalmology Franchise
CHRS
4 Mar 24
:Jodi Sievers, VP Corporate Communications
- Prev
- 1
- Next